Gainers

• Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday's after-market session. The market value of their outstanding shares is at $4.9 million. As per the news, the Q1 earnings report came out 3 days ago.
• Celldex Therapeutics (NASDAQ:CLDX) shares rose 16.05% to $34.99. The market value of their outstanding shares is at $2.3 billion.
• INVO Fertility (NASDAQ:IVF) shares increased by 13.28% to $1.62. The company's market cap stands at $22.6 million.
• Evaxion (NASDAQ:EVAX) shares rose 7.78% to $4.29. The market value of their outstanding shares is at $34.1 million.
• NeuroOne Medical Tech (NASDAQ:NMTC) stock moved upwards by 7.05% to $4.4. The company's market cap stands at $39.0 million.
• BioRestorative Therapies (NASDAQ:BRTX) stock moved upwards by 6.2% to $0.2. The market value of their outstanding shares is at $4.7 million. As per the news, the Q1 earnings report came out 3 days ago.

Losers

• Annovis Bio (NYSE:ANVS) stock declined by 18.1% to $1.59 during Tuesday's after-market session. The company's market cap stands at $71.0 million. The company's, Q1 earnings came out 2 days ago.
• GlucoTrack (NASDAQ:GCTK) shares declined by 17.56% to $0.46. The market value of their outstanding shares is at $1.7 million. As per the news, the Q1 earnings report came out 3 days ago.
• Wellgistics Health (NASDAQ:WGRX) stock decreased by 10.72% to $0.15. The company's market cap stands at $22.0 million. As per the news, the Q1 earnings report came out today.
• NexGel (NASDAQ:NXGL) shares decreased by 10.41% to $0.55. The company's market cap stands at $4.6 million. As per the press release, Q1 earnings came out 3 days ago.
• AIM ImmunoTech (AMEX:AIM) shares fell 9.93% to $0.37. The market value of their outstanding shares is at $6.3 million. As per the press release, Q1 earnings came out 2 days ago.
• Icecure Medical (NASDAQ:ICCM) stock decreased by 7.46% to $0.21. The market value of their outstanding shares is at $17.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.